Is CLL the Second Cancer? A Single Center Retrospective Analysis of Secondary Malignancies (SM) in Patients with Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Akhtar, Othman Salim [1 ]
Singh, Anil [2 ]
Groman, Adrienne [2 ]
Hernandez-Ilizaliturri, Francisco J. [2 ]
机构：
[1] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Dept Med, Buffalo, NY USA
[2] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2018年 / 18卷
关键词：
CLL; secondary cancers; prostate cancer; bladder cancer; renal cell carcinoma;
D O I：
10.1016/j.clml.2018.07.087
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-303
引用
收藏
页码：S219 / S219
页数：1
相关论文
共 50 条
  • [21] Hodgkin's Variant of Richter Transformation in Chronic Lymphocytic Leukemia; A Retrospective Study from the Israeli CLL Study Group
    Tadmor, Tamar
    Shvidel, Lev
    Goldschmidt, Neta
    Ruchlemer, Rosa
    Fineman, Riva
    Bairey, Osnat
    Rahimi-Levene, Naomi
    Herishanu, Yair
    Yuklea, Mona
    Arad, Ariela
    Aviv, Ariel
    Polliack, Aaron
    ANTICANCER RESEARCH, 2014, 34 (02) : 785 - 790
  • [22] Progress in the treatment of elderly/unfit chronic lymphocytic leukemia patients: results of the German CLL-11 trial
    Molica, Stefano
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 9 - 15
  • [23] Retrospective Analysis of Real-World Outcomes of Chronic/ Small Lymphocytic Leukemia (CLL/SLL) Patients Treated With First-Line Ibrutinib Versus Chemoimmunotherapy (CIT)
    Ran, Tao
    He, Jinghua
    Wu, Linda
    Panjabi, Sumeet
    Lu, Xiaoxiao
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S275 - S276
  • [24] Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea
    Yi, Jun Ho
    Lee, Gyeong-Won
    Lee, Ji Hyun
    Yoo, Kwai Han
    Jung, Chul Won
    Kim, Dae Sik
    Lee, Jeong-Ok
    Eom, Hyeon Seok
    Byun, Ja Min
    Koh, Youngil
    Yoon, Sung Soo
    Kim, Jin Seok
    Kong, Jee Hyun
    Yhim, Ho-Young
    Yang, Deok-Hwan
    Yoon, Dok Hyun
    Lim, Do Hyoung
    Lee, Won-Sik
    Shin, Ho-Jin
    BLOOD RESEARCH, 2021, 56 (04) : 243 - 251
  • [25] A phase II study of induction followed by intermittent duvelisib dosing in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Shouse, Geoffrey
    Chen, Lu
    Siddiqi, Tanya
    Muir, Alex
    Brown, Jennifer R.
    Spurgeon, Stephen E.
    Danilov, Alexey V.
    LEUKEMIA & LYMPHOMA, 2024, 65 (10) : 1516 - 1519
  • [26] Changes in Proteome of CLL (Chronic Lymphocytic Leukemia) Lymphocytes During Investigator-Initiated Trial of Ibrutinib Alone and in Combination With Venetoclax in Treatment-Naive Patients With CLL
    Timofeeva, Natalia
    Jain, Nitin
    Irajizad, Ehsan
    Aslan, Burcu
    Katayama, Hiroyuki
    Cai, Yining
    Ayres, Mary
    Iles, Lakesla
    Vykoukal, Jody
    Dennison, Jennifer
    Hanash, Samir
    Wierda, William
    Gandhi, Varsha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S283 - S283
  • [27] Incidence of Second Cancer in Patients with Chronic Lymphocytic Leukemia: The Indian Scenario
    Gogia, Ajay
    Kumar, Lalit
    Sharma, Atul
    Mallick, Saumyaranjan
    Gupta, Ritu
    Rani, Lata
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S316 - S317
  • [28] Isolation of malignant B cells from patients with chronic lymphocytic leukemia (CLL) for analysis of cell proliferation: Validation of a simplified method suitable for multi-center clinical studies
    Hayes, Gregory M.
    Busch, Robert
    Voogt, Jason
    Siah, Iche M.
    Gee, Tracy A.
    Hellerstein, Marc K.
    Chiorazzi, Nicholas
    Rai, Kanti R.
    Murphy, Elizabeth J.
    LEUKEMIA RESEARCH, 2010, 34 (06) : 809 - 815
  • [29] URINARY-EXCRETION OF CD23 ANTIGEN IN NORMAL INDIVIDUALS AND PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    LING, NR
    STEVENSON, FK
    BROWN, B
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 86 (03) : 360 - 366
  • [30] Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission -: experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)
    Wendtner, CM
    Ritgen, M
    Schweighofer, CD
    Fingerle-Rowson, G
    Campe, H
    Jäger, G
    Eichhorst, B
    Busch, R
    Diem, H
    Engert, A
    Stilgenbauer, S
    Döhner, H
    Kneba, M
    Emmerich, B
    Hallek, M
    LEUKEMIA, 2004, 18 (06) : 1093 - 1101
12345